Skip to main content
Divisions
Molecular diagnostics and distributed qPCR solutions.
Complete PCR solutions for molecular diagnostics.
Customised NGS for next-generation molecular insights.
Technologies
Instruments
Miniaturised qPCR devices with superior performance
Software Solutions
Cloud-based platform driven by artificial intelligence for advanced operations
Reagents
Deep multiplexing solutions and innovative reagents for all use cases
About us
Vision & Values
Our identity and the principles that guide the Group.
Numbers and Certifications
Reliability, performance and standards that define our work.
Leadership
The management team leading Helyx Industries.
About Helyx
The history, evolution and culture of our Group.
Insights
See all Insights
12 June 2026 | Vision & Strategy
Beyond the roadmap: the trends that are reshaping molecular diagnostics and Helyx’s market position
In molecular diagnostics, the focus will increasingly shift away from setting out a rigid roadmap and towards building integrated, distributed and manageable architectures. This analysis examines five key structural trends in the sector and how Helyx can interpret them from an industrial perspective.
25 May 2026 | Vision & Strategy
Strategic vision: the future of molecular diagnostics
Molecular diagnostics is evolving from a specialist laboratory function into a distributed, connected infrastructure that is integrated into clinical pathways. This article analyses the key trends – decentralisation, AI, personalised medicine, the cloud, accessibility and regulation – and examines the future of the sector through the Helyx One Group – Three Divisions model.
News
Updates and announcements
08 June 2026
Subsidiary Hyris awarded a public tender in Spain for the supply of SARS-CoV-2 cellular-immunity kits within a public research project
Press releases
29 May 2026
Apertura del nono periodo di esercizio dei "Warrant Helyx Industries S.p.A. 2021-2026" dal 1 al 30 giugno 2026
Press releases
26 May 2026
Integrae SIM avvia la copertura sul titolo
Updates and announcements
18 May 2026
Helyx Industries granted U.S. patent for its proprietary deep multiplexing technology
Investors
Helyx Industries is an industrial group active in the field of genetics. It has proprietary technologies and processes for complete and integrated solutions in molecular biology, from PCR to NGS. Through its divisions, it offers its solutions directly to diagnostic laboratories and hospitals or provides its services to diagnostic and industrial partners. Helyx Industries is listed on Euronext Growth in Milan.
Read more
Contact us
IT
EN
IT
EN
Divisions
Molecular diagnostics and distributed qPCR solutions.
Hyris System™
Agrifood & Nutraceuticals Catalogue
Development and OEM services
Complete PCR solutions for molecular diagnostics.
Human Health Catalogue
Customised NGS for next-generation molecular insights.
Customised NGS panels
Compatible areas & technologies
Technologies
Instruments
Miniaturised qPCR devices with superior performance
bCUBE™
bGATE™
Software Solutions
Cloud-based platform driven by artificial intelligence for advanced operations
bAPP™
Reagents
Deep multiplexing solutions and innovative reagents for all use cases
Sagitta™
Stable multiplex reagents
About Us
Vision & Values
Our identity and the principles that guide the Group.
Vision
Mission
Numbers and Certifications
Reliability, performance and standards that define our work.
Facts and Figures
Certifications
Leadership
The management team leading Helyx Industries.
People
About Helyx
The history, evolution and culture of our Group.
Our History
Timeline
Insights
News
Updates & announcements
Commercial news announced by Helyx Industries.
Read all
Press releases
Regulated and price-sensitive press releases.
Read all
Scientific Publications
Research, studies and published scientific papers.
Read all
Investors
Helyx Industries
Helyx Industries is an integrated biotech group with proprietary technologies that develops diagnostic solutions, focusing on public health, distributed diagnostics and molecular innovation.
Download Pitch Deck
Overview
Corporate Governance
Information for shareholders
Financial data
Press releases
Financial calendar
Shareholders' meeting
Analyst Coverage
Warrant
Internal dealing
Investment Agreement with GCF
Concluded extraordinary transactions
IPO
Investor Relations Contacts
Contacts
Go to section…
Overview
Corporate Governance
Information for shareholders
Financial Data
Press releases
Financial Calendar
Shareholders' meeting
Analyst Coverage
Warrant
Internal dealing
Investment Agreement with GCF
Concluded extraordinary transactions
IPO
Investor Relations Contacts
Investor Relations Contacts
Gabriele Salaris
Email
This email address is being protected from spambots. You need JavaScript enabled to view it.
Telefono
+39 040 3757540
Investor Relations Manager
Contact
Gabriele Salaris
Email
This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone
+39 040 3757540
Email
This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone
+39 040 3757540
